首页> 外文期刊>Journal of investigative medicine >Significance of hepatitis C virus core protein in the diagnosis of hepatitis C virus infection in different liver diseases.
【24h】

Significance of hepatitis C virus core protein in the diagnosis of hepatitis C virus infection in different liver diseases.

机译:丙型肝炎病毒核心蛋白在不同肝病中丙型肝炎病毒感染的诊断中的意义。

获取原文
获取原文并翻译 | 示例
           

摘要

The present article describes the presence of hepatitis C virus (HCV) core protein in relation to HCV antibody in different types of liver diseases caused by hepatitis viral infections. One hundred thirty patients with various types of liver diseases, including those with acute viral hepatitis (n = 50), chronic viral hepatitis (n = 30), cirrhosis of the liver (n = 30), and fulminant hepatic failure (n = 20), were analyzed for HCV core protein, HCV-ribonucleic acid (RNA) and anti-HCV antibodies using enzyme immunoassays and reverse transcriptase-polymerase chain reaction. All patients were also simultaneously analyzed for other hepatitis markers to diagnose hepatitis A to E in all cases. Patients with HCV infection were additionally tested for HCV core protein and HCV-RNA. The results of analysis demonstrated the presence of hepatitis B, C, and E in different proportions of patients with these liver diseases. Hepatitis A and D infections were absent in all cases. Analysis of sera from acute viral hepatitis demonstrated the presence of HCV core protein, HCV-RNA, anti-HCV antibodies, and both core protein and anti-HCV together in 18%, 16%, 6%, and 2% of cases, respectively. In fulminant hepatic failure patients, these markers were recorded in 20%, 10%, 10%, and 5% of cases, respectively. In the chronic viral hepatitis group, the pattern was reversed, and their presence was recorded in 13.3%, 13.3%, 46.6%, and 10% of cases, respectively. Similarly, in cirrhosis patients, these markers were noted in 23.3%, 23.3%, 23.3%, and 13.3% of cases, respectively. None of the control sera were positive for any hepatitis marker. The significance of HCV core protein in relation to HCV-RNA and anti-HCV for the diagnosis of HCV infection in different liver diseases has been discussed.
机译:本文介绍了丙型肝炎病毒(HCV)核心蛋白与丙型肝炎病毒抗体相关的存在于由肝炎病毒感染引起的不同类型的肝脏疾病中。 130名患有各种肝病的患者,包括急性病毒性肝炎(n = 50),慢性病毒性肝炎(n = 30),肝硬化(n = 30)和暴发性肝衰竭(n = 20)使用酶免疫法和逆转录酶-聚合酶链反应分析HCV核心蛋白,HCV核糖核酸(RNA)和抗HCV抗体。还对所有患者同时进行其他肝炎标志物分析,以在所有情况下诊断出甲型至戊型肝炎。 HCV感染患者还需要进行HCV核心蛋白和HCV-RNA检测。分析结果表明,不同比例的这些肝病患者存在乙型,丙型和戊型肝炎。所有病例均不存在甲型和丁型肝炎感染。对急性病毒性肝炎血清的分析表明,分别有18%,16%,6%和2%的病例同时存在HCV核心蛋白,HCV-RNA,抗HCV抗体以及核心蛋白和抗HCV 。在暴发性肝衰竭患者中,分别在20%,10%,10%和5%的病例中记录了这些标志物。在慢性病毒性肝炎组中,这种情况发生了逆转,分别记录为病例的13.3%,13.3%,46.6%和10%。同样,在肝硬化患者中,分别在23.3%,23.3%,23.3%和13.3%的病例中注意到这些标志物。对照血清均无肝炎标志阳性。讨论了HCV核心蛋白与HCV-RNA和抗HCV的关系对诊断不同肝脏疾病中HCV感染的意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号